This study evaluates the pharmacokinetic toxicity and therapeutic efficacy of escalating doses of dideoxyinosine (ddI) given once a day for the treatment of A and ARC. Amendments have included a pharmacokinetic study of ddI with Gancyclovir in patients with CMV infections and AIDS. Patients are followed for the effects of longterm therapy on ddI.
Showing the most recent 10 out of 476 publications